The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects

Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Tingting, Wang, Yitong, Liang, Shuyao, Han, Ru, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Keynote (Green)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057929/
https://www.ncbi.nlm.nih.gov/pubmed/33892148
http://dx.doi.org/10.1016/j.drudis.2021.04.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057929/
https://www.ncbi.nlm.nih.gov/pubmed/33892148
http://dx.doi.org/10.1016/j.drudis.2021.04.020

Ejemplares similares